Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure

2008 ◽  
Vol 26 (10) ◽  
pp. 879-889 ◽  
Author(s):  
Guiqing Yao ◽  
Nick Freemantle ◽  
Marcus Flather ◽  
Puvan Tharmanathan ◽  
Andrew Coats ◽  
...  
Keyword(s):  
Heart Failure ◽  
Cost Effectiveness ◽  
Elderly Patients ◽  
Standard Care ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
Patients With Heart Failure

Cost-effectiveness analysis of long-term moderate exercise training in chronic heart failure

2001 ◽  
Vol 87 (8) ◽  
pp. 984-988 ◽  
Author(s):  
Demetrios Georgiou ◽  
Yu Chen ◽  
Sheila Appadoo ◽  
Romualdo Belardinelli ◽  
Richard Greene ◽  
...  
Keyword(s):  
Heart Failure ◽  
Cost Effectiveness ◽  
Chronic Heart Failure ◽  
Exercise Training ◽  
Cost Effectiveness Analysis ◽  
Moderate Exercise ◽  
Effectiveness Analysis ◽  
Moderate Exercise Training

scholarly journals Cost-effectiveness analysis of telemonitoring versus usual care in patients with heart failure (the TEHAF-study)

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. P3346-P3346 ◽  
Author(s):  
J. Boyne ◽  
A. D. I. Van Asselt ◽  
A. P. M. Gorgels ◽  
L. M. G. Steuten ◽  
J. Kragten ◽  
...  
Keyword(s):  
Heart Failure ◽  
Cost Effectiveness ◽  
Usual Care ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
Patients With Heart Failure

Nice Guideline on Osteoarthritis: Is it Fair to Acupuncture? No

2009 ◽  
Vol 27 (2) ◽  
pp. 70-72 ◽  
Author(s):  
Adrian White
Keyword(s):  
Cost Effectiveness ◽  
Standard Care ◽  
Clinical Excellence ◽  
Sham Acupuncture ◽  
Cost Effectiveness Analysis ◽  
Insufficient Evidence ◽  
Nice Guideline ◽  
Effectiveness Analysis ◽  
The Cost

A new guideline on the care and management of osteoarthritis has recently been published by the National Institute for Health and Clinical Excellence, and makes wide-ranging and authoritative recommendations. The guideline states that there is insufficient evidence to recommend acupuncture. There appears to be three areas where the guidelines may have not used the available evidence in the most appropriate manner. First, data on the long-term effectiveness of acupuncture may have been misinterpreted. Second, the specific rejection of electroacupuncture indicates a restricted understanding of acupuncture as a treatment, and is based on a cost-effectiveness analysis which may not be ideal. Third, the cost-effectiveness calculations used comparisons with sham acupuncture (“placebo”) when comparison with standard care would have been more appropriate. The guideline may therefore lead some patients with osteoarthritis to miss out on a treatment that may be effective for them.

scholarly journals Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction

2016 ◽  
Vol 1 (6) ◽  
pp. 666 ◽  
Author(s):  
Thomas A. Gaziano ◽  
Gregg C. Fonarow ◽  
Brian Claggett ◽  
Wing W. Chan ◽  
Celine Deschaseaux-Voinet ◽  
...  
Keyword(s):  
Heart Failure ◽  
Cost Effectiveness ◽  
Ejection Fraction ◽  
Cost Effectiveness Analysis ◽  
Reduced Ejection Fraction ◽  
Effectiveness Analysis ◽  
Patients With Heart Failure
Sign in / Sign up

Export Citation Format

Share Document